Literature DB >> 21041778

Current understanding and management of Parkinson disease: five new things.

James F Morley1, Howard I Hurtig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21041778     DOI： 10.1212/WNL.0b013e3181fb3628

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

Review 1.  Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration.

Authors:  Talita Glaser; Angélica Regina Cappellari; Micheli Mainardi Pillat; Isabele Cristiana Iser; Márcia Rosângela Wink; Ana Maria Oliveira Battastini; Henning Ulrich
Journal:  Purinergic Signal       Date:  2011-12-06       Impact factor: 3.765

2.  Protection of dopaminergic neurons in a mouse model of Parkinson's disease by a physically-modified saline containing charge-stabilized nanobubbles.

Authors:  Saurabh Khasnavis; Avik Roy; Supurna Ghosh; Richard Watson; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2014-03       Impact factor: 4.147

Review 3.  Rafts, Nanoparticles and Neural Disease.

Authors:  Vishal Gulati; Ron Wallace
Journal:  Nanomaterials (Basel)       Date:  2012-08-06       Impact factor: 5.076

4.  Non-motor symptoms are associated with REM sleep behavior disorder in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Dan Xie; Qiuyan Shen; Junying Zhou; Yanming Xu
Journal:  Neurol Sci       Date:  2020-10-06       Impact factor: 3.307

5.  Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein.

Authors:  Stav Kemeny; Dikla Dery; Yelena Loboda; Marshall Rovner; Tali Lev; Dotan Zuri; John P M Finberg; Sarit Larisch
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.